IL85627A - Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts - Google Patents

Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts

Info

Publication number
IL85627A
IL85627A IL85627A IL8562788A IL85627A IL 85627 A IL85627 A IL 85627A IL 85627 A IL85627 A IL 85627A IL 8562788 A IL8562788 A IL 8562788A IL 85627 A IL85627 A IL 85627A
Authority
IL
Israel
Prior art keywords
metformin
salts
treatment
disorders
pharmaceutical compositions
Prior art date
Application number
IL85627A
Other languages
English (en)
Other versions
IL85627A0 (en
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of IL85627A0 publication Critical patent/IL85627A0/xx
Publication of IL85627A publication Critical patent/IL85627A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL85627A 1987-03-06 1988-03-03 Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts IL85627A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8703028A FR2611500B1 (fr) 1987-03-06 1987-03-06 Emploi de derives du biguanide dans la preparation de medicaments

Publications (2)

Publication Number Publication Date
IL85627A0 IL85627A0 (en) 1988-08-31
IL85627A true IL85627A (en) 1993-01-14

Family

ID=9348653

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85627A IL85627A (en) 1987-03-06 1988-03-03 Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts

Country Status (10)

Country Link
EP (1) EP0283369B1 (de)
JP (1) JPH0818978B2 (de)
AT (1) ATE98120T1 (de)
AU (1) AU610134B2 (de)
CA (1) CA1328606C (de)
DE (1) DE3886075T2 (de)
DK (1) DK169713B1 (de)
FR (1) FR2611500B1 (de)
IL (1) IL85627A (de)
ZA (1) ZA881540B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100919A (en) * 1984-03-19 1992-03-31 The Rockefeller University Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein
US5356913A (en) * 1990-02-09 1994-10-18 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
DE69100282T3 (de) * 1990-02-09 2001-01-11 Pharmacia & Upjohn Co., Kalamazoo Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
AU3631795A (en) * 1994-09-15 1996-03-29 Pharmagenesis, Inc. Composition and method for immunotherapy
ES2216335T3 (es) * 1997-12-08 2004-10-16 Bristol-Myers Squibb Company Nuevas sales de metformina y procedimiento.
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
JP4606582B2 (ja) * 1998-04-29 2011-01-05 大日本住友製薬株式会社 ビグアナイド系薬物の内服製剤
AU3536299A (en) * 1998-04-29 1999-11-16 Sumitomo Pharmaceuticals Company, Limited Oral formulation comprising biguanide and an organic acid
DE69831940T2 (de) * 1998-07-30 2006-04-20 Merck Santé Tablette mit verlängerter Wirkstoffabgabe im Magen
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
FR2796551B1 (fr) * 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940B1 (fr) * 1999-07-26 2005-04-08 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2809310B1 (fr) * 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
WO2002012177A1 (en) * 2000-08-03 2002-02-14 Igor Anatolievich Pomytkin Composition of metformin with succinic acid or salts thereof and method for treating diabetes
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP1945190A1 (de) * 2005-09-22 2008-07-23 Swissco Devcelopment AG Sprudelnde metformin-zusammensetzung und daraus hergestellte tabletten und granulate
CN105152983A (zh) 2007-01-29 2015-12-16 韩诺生物制药株式会社 N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
GR1007299B (el) * 2010-03-24 2011-06-06 Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2448448A (en) * 1942-06-08 1948-08-31 Courtaulds Ltd Dyeing of textile fibers containing nitrogen

Also Published As

Publication number Publication date
DE3886075D1 (de) 1994-01-20
FR2611500A1 (fr) 1988-09-09
AU1272788A (en) 1988-09-08
EP0283369B1 (de) 1993-12-08
IL85627A0 (en) 1988-08-31
EP0283369A3 (en) 1989-11-29
DE3886075T2 (de) 1994-04-14
ZA881540B (en) 1988-08-26
EP0283369A2 (de) 1988-09-21
DK116788D0 (da) 1988-03-04
ATE98120T1 (de) 1993-12-15
AU610134B2 (en) 1991-05-16
DK169713B1 (da) 1995-01-23
DK116788A (da) 1988-09-07
JPH0818978B2 (ja) 1996-02-28
FR2611500B1 (fr) 1990-05-04
CA1328606C (fr) 1994-04-19
JPS63230628A (ja) 1988-09-27

Similar Documents

Publication Publication Date Title
IL85627A (en) Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
FI862011A (fi) Terapeutiska nukleosider.
EP0397697A4 (en) Quinoline derivatives as antagonists of leukotriene d 4?
PH25313A (en) Carboxylic acid derivatives, pharmaceutical compositions containing them
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
PT87470A (pt) Process for the preparation of novel substituted benzamides and of pharmaceutical compositions containing the same
DE3875769D1 (de) Therapeutische nukleoside.
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
DE3460620D1 (en) Pharmaceutical or veterinary composition for the treatment of ischemic cardiac disorders
ES462387A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridin-azucar.
ATE58829T1 (de) Mittel mit kontinuierlicher freisetzung von phenylethanolaminderivaten.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.

Legal Events

Date Code Title Description
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
EXP Patent expired